1. Home
  2. AUID vs OSRH Comparison

AUID vs OSRH Comparison

Compare AUID & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo authID Inc.

AUID

authID Inc.

N/A

Current Price

$0.48

Market Cap

18.4M

Sector

Technology

ML Signal

N/A

Logo OSR Holdings Inc.

OSRH

OSR Holdings Inc.

N/A

Current Price

$0.11

Market Cap

17.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AUID
OSRH
Founded
2009
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
18.4M
17.9M
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
AUID
OSRH
Price
$0.48
$0.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
256.9K
23.9M
Earning Date
05-12-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
60.00
N/A
EPS
N/A
N/A
Revenue
$2,040,660.00
$2,905,805.00
Revenue This Year
N/A
$9.30
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
130.20
N/A
52 Week Low
$0.34
$0.24
52 Week High
$4.58
$0.95

Technical Indicators

Market Signals
Indicator
AUID
OSRH
Relative Strength Index (RSI) 34.45 N/A
Support Level $0.34 N/A
Resistance Level $1.41 N/A
Average True Range (ATR) 0.08 0.00
MACD 0.01 0.00
Stochastic Oscillator 27.90 0.00

Price Performance

Historical Comparison
AUID
OSRH

About AUID authID Inc.

AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.

About OSRH OSR Holdings Inc.

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. The company's pipeline products include: Vaximm, Darnatein, Woori IO, and RMC.

Share on Social Networks: